| Title |
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial
|
|---|---|
| Published in |
BMC Cancer, December 2012
|
| DOI | 10.1186/1471-2407-12-603 |
| Pubmed ID | |
| Authors |
David Pérol, Jocelyne Provençal, Anne-claire Hardy-Bessard, David Coeffic, Jean-Phillipe Jacquin, Cécile Agostini, Thomas Bachelot, Jean-Paul Guastalla, Xavier Pivot, Jean-Pierre Martin, Agathe Bajard, Isabelle Ray-Coquard |
| Abstract |
Chemotherapy induced nausea and vomiting (CINV) remains a major problem that seriously impairs the quality of life (QoL) in cancer patients receiving chemotherapy regimens. Complementary medicines, including homeopathy, are used by many patients with cancer, usually alongside with conventional treatment. A randomized, placebo-controlled Phase III study was conducted to evaluate the efficacy of a complex homeopathic medicine, Cocculine, in the control of CINV in non-metastatic breast cancer patients treated by standard chemotherapy regimens. |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ireland | 4 | 18% |
| United Kingdom | 4 | 18% |
| Canada | 2 | 9% |
| Netherlands | 1 | 5% |
| United States | 1 | 5% |
| Kuwait | 1 | 5% |
| Australia | 1 | 5% |
| France | 1 | 5% |
| Unknown | 7 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 45% |
| Practitioners (doctors, other healthcare professionals) | 6 | 27% |
| Science communicators (journalists, bloggers, editors) | 3 | 14% |
| Scientists | 3 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 111 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 30 | 27% |
| Researcher | 18 | 16% |
| Student > Master | 9 | 8% |
| Other | 8 | 7% |
| Student > Doctoral Student | 6 | 5% |
| Other | 13 | 12% |
| Unknown | 29 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 41 | 36% |
| Nursing and Health Professions | 11 | 10% |
| Agricultural and Biological Sciences | 8 | 7% |
| Psychology | 6 | 5% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Other | 11 | 10% |
| Unknown | 31 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2022.
All research outputs
#1,088,955
of 25,218,929 outputs
Outputs from BMC Cancer
#140
of 8,904 outputs
Outputs of similar age
#8,210
of 272,957 outputs
Outputs of similar age from BMC Cancer
#3
of 108 outputs
Altmetric has tracked 25,218,929 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,904 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,957 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.